-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Integrating Risk Factor Management of Coronary Heart Disease into Managed Care

Goals and Objectives

By

March 1st 1997

Introduction

By

March 1st 1997

Applying Lipid Clinical Trials to the Practical Management of High-Risk Patients

By

March 1st 1997

Integrating Risk Factor Management into the Care of the Cardiac Patient

By

March 1st 1997

Risk-Factor Management in Women and Other Special Patients

By

March 1st 1997

Clinical Implications of Recent Cholesterol Lowering Trials for the Secondary Prevention of Coronary Heart Disease

ByRobert A. Vogel, MD

March 1st 1997

Risk Factor Management: Exploring the Boundaries

ByKillian Robinson, MD

March 1st 1997

CME Quiz

By

March 1st 1997

Bibliography

By

March 1st 1997

Converting Clinical Lipid Trials into the Practical Management of High-Risk Patients: New NECP Thoughts on Treating CHD Patients

ByScott Grundy, MD, PhD

March 1st 1997

Review of the NIH Post-CABG Study and Future Advances in HMG-CoA Therapy

ByDavid B. Hunninghake, MD

March 1st 1997

Accuracy of Lipid Profiles in the Hospital Setting: Impact on the Initiation of Cholesterol-Lowering Therapy

ByLeonard Keilson, MD, MPH

March 1st 1997

The Undertreatment Problem: Identifying Barriers to Treatment

ByR. Wayne Alexander, MD, PhD

March 1st 1997

Practical Disease Management as a Solution to the Undertreatment Problem

ByRichard C. Pasternak, MD

March 1st 1997

Impact of Risk Factor Modification on the CHD Process

ByValentin Fuster, MD, PhD

March 1st 1997

Major Clinical Trials: Pharmacologic Therapy in Higher Risk Patients

BySidney C. Smith, Jr, MD

March 1st 1997

Lack of Intensive Treatment of CHD Risk Factors: Could the Physician Be the Most Important Risk Factor?

ByRobert A. Vogel, MD

March 1st 1997

Risk Factor Management and the Interventionalist: Treating the Patient, Not Just the Lesion

ByJeffrey J. Popma, MD

March 1st 1997

The Role of the Nurse Case Manager

ByNancy Houston-Miller, RN, BSN

March 1st 1997

The Role of the Managed Care Industry

BySidney C. Smith, Jr, MD

March 1st 1997

Lessons Learned from Lipid-Lowering Trials That Have Included Women

ByThomas A. Pearson, MD, PhD,Tatu A. Miettinen, MD

March 1st 1997

Identifying Women at Risk and Providing Protective Measures

ByMillicent Higgins, MD,Elizabeth Barrett-Connor, MD

March 1st 1997

What Do Recent Trials Tell Us About Statins?

ByAnne C. Goldberg, MD

March 1st 1997

Strategies to Enhance Risk Factor Management in Clinical Practice

ByNancy Houston-Miller, RN, BSN

March 1st 1997

Safety and Tolerability of Lipid-Lowering Drugs After Heart Transplantation: The Heart Transplant Lipid Registry

ByChristie M. Ballantyne, MD

March 1st 1997

Possible Use of Ultrafast CT of Coronaries to Make Decisions in Hyperlipidemic Patients

ByLinda L. Demer, MD, PhD

March 1st 1997

Treatment of Combined Hyperlipidemia: Whether and How

ByRobert H. Knopp, MD

March 1st 1997

Participants

By

March 1st 1997

Trending on AJMC

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

ATTR-CM Incidence, Prevalence Rose Sharply in the US

FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Zanubrutinib Tops Rivals in Real-World CLL Survival Study